UBS Upgrades AstraZeneca (AZN) to Buy; Shares on the Move
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Price: $52.17 +0.17%
Rating Summary:
2 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
2 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade AZN Now!
AstraZeneca (NYSE: AZN) shares have been volatile over the last half-hour of trading as we are hearing UBS upgraded the stock from Neutral to Buy in an intraday research report.
The stock is now up 0.8 percent to $51.78; about 20 minutes ago, AZN shares had been trading as low as $51.60.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is now up 0.8 percent to $51.78; about 20 minutes ago, AZN shares had been trading as low as $51.60.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Topeka Capital Upgrades Pacific Sunwear of California (PSUN) to Buy
- Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
Create E-mail Alert Related Categories
UpgradesRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
